Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Conditions:   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: vorinostat;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Procedure: positron emission tomography;   Radiation: F-18 16 alpha-fluoroestradiol;   Radiation: fludeoxyglucose F 18;   Other: laboratory biomarker analysisSponsors:   Fred Hutchinson Cancer Research Center;   Fred Hutchinson Cancer Research Cent...
Source: ClinicalTrials.gov - October 31, 2012 Category: Research Source Type: clinical trials

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Conditions:   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: vorinostat;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Procedure: positron emission tomography;   Radiation: F-18 16 alpha-fluoroestradiol;   Radiation: fludeoxyglucose F 18;   Other: laboratory biomarker analysisSponsors:   Fred Hutchinson Cancer Research Center;   Fred Hutchinson Cancer Research Cent...
Source: ClinicalTrials.gov - October 31, 2012 Category: Research Source Type: clinical trials

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Conditions:   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: vorinostat;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Procedure: positron emission tomography;   Radiation: F-18 16 alpha-fluoroestradiol;   Radiation: fludeoxyglucose F 18;   Other: laboratory biomarker analysisSponsors:   Fred Hutchinson Cancer Research Center;   Fred Hutchinson Cancer Research Cent...
Source: ClinicalTrials.gov - October 31, 2012 Category: Research Source Type: clinical trials

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Conditions:   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: vorinostat;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Procedure: positron emission tomography;   Radiation: F-18 16 alpha-fluoroestradiol;   Radiation: fludeoxyglucose F 18;   Other: laboratory biomarker analysisSponsors:   University of Washington;   National Cancer Institute (NCI)Recruiting - v...
Source: ClinicalTrials.gov - October 31, 2012 Category: Research Source Type: clinical trials

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Conditions:   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: vorinostat;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Procedure: positron emission tomography;   Radiation: F-18 16 alpha-fluoroestradiol;   Radiation: fludeoxyglucose F 18;   Other: laboratory biomarker analysisSponsors:   University of Washington;   National Cancer Institute (NCI)Recruiting - v...
Source: ClinicalTrials.gov - October 31, 2012 Category: Research Source Type: clinical trials